Majority woman-owned impact fund investing in AI and big-data diagnostic innovations to enable earlier, more precise, and more accessible detection. Focus areas include breast and other cancers, cardiovascular and kidney diseases, Alzheimer’s, and mental health; aims to reduce invasiveness and lower costs.